Doximity, Inc. (NYSE:DOCS) Receives Average Rating of “Hold” from Brokerages

Posted by on Jul 4th, 2026

Doximity, Inc. (NYSE:DOCS – Get Free Report) has received an average rating of “Hold” from the twenty-four ratings firms that are covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a sell recommendation, twelve have assigned a hold recommendation, six have issued a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $29.3333.

Several equities analysts have recently commented on DOCS shares. Loop Capital set a $31.00 price objective on shares of Doximity in a research note on Tuesday, March 17th. Wells Fargo & Company reissued an “equal weight” rating and issued a $18.00 target price (down from $32.00) on shares of Doximity in a research note on Thursday, May 14th. KeyCorp downgraded Doximity from an “overweight” rating to a “sector weight” rating in a report on Thursday, May 14th. Barclays reaffirmed an “equal weight” rating and set a $20.00 price target (down from $38.00) on shares of Doximity in a research report on Thursday, May 14th. Finally, Citigroup cut Doximity to an “underperform” rating in a report on Monday.

Check Out Our Latest Stock Analysis on DOCS

Insider Buying and Selling

In related news, insider Siddharth Sitaram sold 2,444 shares of the company’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $20.41, for a total transaction of $49,882.04. Following the completion of the transaction, the insider owned 90,706 shares in the company, valued at $1,851,309.46. This represents a 2.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the firm’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $26.06, for a total value of $234,540.00. Following the completion of the sale, the director directly owned 19,839 shares of the company’s stock, valued at $517,004.34. The trade was a 31.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 16,180 shares of company stock valued at $395,110. 31.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Doximity

Institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in shares of Doximity by 4.1% during the 4th quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company’s stock valued at $588,281,000 after purchasing an additional 518,916 shares in the last quarter. Capital World Investors raised its stake in Doximity by 5.1% in the fourth quarter. Capital World Investors now owns 5,654,875 shares of the company’s stock worth $250,398,000 after buying an additional 273,444 shares in the last quarter. Carmignac Gestion raised its stake in Doximity by 127.8% in the first quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock worth $100,480,000 after buying an additional 2,418,971 shares in the last quarter. Franklin Resources Inc. lifted its holdings in Doximity by 6.2% in the third quarter. Franklin Resources Inc. now owns 3,357,505 shares of the company’s stock worth $245,601,000 after buying an additional 194,912 shares during the period. Finally, Renaissance Technologies LLC lifted its holdings in Doximity by 29.4% in the first quarter. Renaissance Technologies LLC now owns 3,059,749 shares of the company’s stock worth $71,292,000 after buying an additional 694,300 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Stock Up 0.0%

Shares of Doximity stock opened at $21.86 on Friday. The firm has a market cap of $4.00 billion, a PE ratio of 22.09, a price-to-earnings-growth ratio of 6.79 and a beta of 1.30. Doximity has a 12-month low of $17.15 and a 12-month high of $76.51. The company’s fifty day simple moving average is $21.62 and its two-hundred day simple moving average is $28.20.

Doximity Company Profile

(Get Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.

Featured Articles

Analyst Recommendations for Doximity (NYSE:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.